Page 168 - 《南京医科大学学报》2026年第1期

第46卷第1期
· 162 · 南 京 医 科 大 学 学 报 2026年1月

1858（7）：519-528 ［65］RAGHUBEER S，NAGIAH S，PHULUKDAREE A，et al.
［54］VENKATESH S，LI M，SAITO T，et al. Mitochondrial The phytoalexin resveratrol ameliorates ochratoxin a toxic⁃
LONP1 protects cardiomyocytes from ischemia/reperfu⁃ ity in human embryonic kidney（HEK293）cells［J］. J Cell
sion injury in vivo［J］. J Mol Cell Cardiol，2019，128：38- Biochem，2015，116（12）：2947-2955
50 ［66］KIM J E，PARK H，KIM T H，et al. LONP1 regulates mi⁃
［55］ONAT U I，YILDIRIM A D，TUFANLI Ö，et al. Intercept⁃ tochondrial accumulations of HMGB1 and Caspase⁃ 3 in
ing the lipid⁃induced integrated stress response reduces CA1 and PV neurons following status epilepticus［J］. Int
atherosclerosis［J］. J Am Coll Cardiol，2019，73（10）： J Mol Sci，2021，22（5）：2275
1149-1169 ［67］WANG W Z，MA X P，BHATTA S，et al. Intraneuronal β⁃
［56］HOSHINO A，OKAWA Y，ARIYOSHI M，et al. Oxidative amyloid impaired mitochondrial proteostasis through the
post⁃translational modifications develop LONP1 dysfunc⁃ impact on LONP1［J］. Proc Natl Acad Sci U S A，2023，
tion in pressure overload heart failure［J］. Circ Heart Fail， 120（51）：e2316823120
2014，7（3）：500-509 ［68］XU D，ZHANG Z，ZHU Z，et al. Decreased LONP1 ex⁃
［57］LI M K，ZHANG W K，ZHANG M H，et al. LONP1 facili⁃ pression exacerbates MASH⁃induced liver fibrosis via ele⁃
tates pulmonary artery smooth muscle cell glycolytic re⁃ vated orotic acid levels［J］. J Hepatol，2025，8：0168⁃8278
programming by degrading MPC1 in pulmonary hyperten⁃ （25）02379-7
sion［J］. Clin Sci（Lond），2025，139（10）：479-501 ［69］WU M C，WU J，LIU K，et al. LONP1 ameliorates liver in⁃
［58］XU Z S，FU T T，GUO Q Q，et al. Disuse⁃associated loss jury and improves gluconeogenesis dysfunction in acute⁃
of the protease LONP1 in muscle impairs mitochondrial on⁃chronic liver failure［J］. Chin Med J（Engl），2024，137
function and causes reduced skeletal muscle mass and （2）：190-199
strength［J］. Nat Commun，2022，13（1）：894 ［70］HOU Q，CHENG S，LI Z，et al. Peste des petits ruminants
［59］HUANG S Y，WANG X N，YU J L，et al. LonP1 regulates virus（PPRV）induces ferroptosis via LONP1 ⁃ mediated
mitochondrial network remodeling through the PINK1/ mitochondrial GPX4 degradation in cell culture［J］. J Vi⁃
Parkin pathway during myoblast differentiation［J］. Am J rol，2025，99（5）：e0231024
Physiol Cell Physiol，2020，319（6）：C1020-c1028 ［71］LI J，DENG Y，GASSER M，et al. LONP1 regulation of mi⁃
［60］KNUTH C M，AUGER C，JESCHKE M G. Burn⁃induced tochondrial protein folding provides insight into beta cell
hypermetabolism and skeletal muscle dysfunction［J］. failure in type 2 diabetes［J］. Nat Metab，2025，7（8）：
Am J Physiol Cell Physiol，2021，321（1）：C58-C71 1570-1592
［61］HE Y Z，DING Q H，CHEN W L，et al. LONP1 downregu⁃ ［72］FAN J，XU X，LI Y，et al. A novel 3⁃phenylglutaric acid
lation with ageing contributes to osteoarthritis via mito⁃ derivative（84 ⁃ B10）alleviates cisplatin ⁃ induced acute
chondrial dysfunction［J］. Free Radic Biol Med，2022， kidney injury by inhibiting mitochondrial oxidative stress⁃
191：176-190 mediated ferroptosis［J］. Free Radic Biol Med，2023，194：
［62］GONG W，SONG J Y，LIANG J，et al. Reduced Lon prote⁃ 84-98
ase 1 expression in podocytes contributes to the pathogen⁃ ［73］XU X Y，ZHU W P，MIAO M Q，et al. Activation of
esis of podocytopathy［J］. Kidney Int，2021，99（4）：854- LONP1 by 84⁃B10 alleviates aristolochic acid nephropa⁃
869 thy via re⁃establishing mitochondrial and peroxisomal ho⁃
［63］BAI M，WU M，JIANG M，et al. LONP1 targets HMGCS2 meostasis［J］. Chin J Nat Med，2024，22：808-821
to protect mitochondrial function and attenuate chronic ［74］SU M，LIU X R，ZHAO Y R，et al. In silico and in vivo
kidney disease［J］. EMBO Mol Med，2023，15（2）：16581 pharmacokinetic evaluation of 84⁃B10，a novel drug can⁃
［64］ZHANG B Y，SHEN X L，LIANG R，et al. Protective role didate against acute kidney injury and chronic kidney dis⁃
of the mitochondrial LON protease 1 in ochratoxin A⁃in⁃ ease［J］. Molecules，2023，29（1）：159
duced cytotoxicity in HEK293 cells［J］. J Proteomics， （收稿：2025-08-18；修回：2025-11-13；录用：2025-11-17）
2014，101：154-168 （本文编辑：唐 震）